The U.S. Food and Drug Administration (FDA) has accepted a new drug application for iberdomide combined with Darzalex (daratumumab) and dexamethasone (IberDd) for the treatment of patients with ...

The NDA is supported by data from part A of the phase 2 PROSPECT trial, which evaluated tirabrutinib in 48 adult patients with R/R PCNSL.

FDA accepted a new drug application for tirabrutinib in relapsed or refractory PCNSL.

Update below: Our William Breathes has been closely following the fate of approximately 4,000 medical marijuana applications put on hold by the Colorado Department of Public Health and Environment, ...

A growing number of patient population groups are using mobile health apps and self-monitoring technology (which include interactive tablets and smartphone applications,such as the Clear Arch Mobile ...

Please provide your email address to receive an email when new articles are posted on . Patients with drug-eluting stents who used a computer tablet application were 10% more likely to correctly ...

This article is part of a series sponsored by HLTH highlighting topics that will be discussed at the HLTH conference November 13-16 in Las Vegas. Register today. Remote patient monitoring is one of ...

Patients with diabetes often have to see many different stakeholders who each specialise in different aspects of their treatment. Researchers from WMG, University of Warwick surveyed patients on their ...